Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats.
Epidemiological studies suggest that even in the absence of other risk factors advanced age itself significantly increases cardiovascular morbidity. Age aggravated inflammatory activity further plays a central role in the pathogenesis of atherosclerosis and its complications. EGCG, a major flavonoid present in green tea extract has been proved to be useful in lowering cholesterol levels thereby slowing down the progression of cardiovascular diseases in young animals. Thus, the endeavor of this study was to assess the impact of high-cholesterol diet on aging and vice versa and to exploit the potential of EGCG to combat age-associated hypercholesterolemia and mitigate inflammation. Male albino rats of Wistar strain (3 months-young and 24 months old-aged) were used in this study. Hypercholesterolemia was induced by the diet comprising of the normal rat chow supplemented with 4% cholesterol and 1% cholic acid. EGCG (100 mg/kg body weight/day) was given orally for 30 days. The results revealed abnormally elevated lipid levels, marker enzymes and inflammatory markers in serum of aged hypercholesterolemic rats when compared to young hypercholesterolemic rats, while treatment with EGCG partially reversed these aberrations. The present work demonstrates the inflammatory responses in hypercholesterolemic atherogenesis during aging and further underscores the salubrious role played by the EGCG in attenuating the inflammatory and lipid anomalies.
Senthil Kumaran
Vadivel
V
Department of Medical Biochemistry, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai 600 113, India.
Arulmathi
Karpagavinayagam
K
Sundarapandiyan
Rajaguru
R
Kalaiselvi
Periandavan
P
D000375:Aging / Q000502:physiology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D050197:Atherosclerosis / Q000097:blood / Q000503:physiopathology / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004036:Diet, Atherogenic; D006937:Hypercholesterolemia / Q000097:blood* / Q000503:physiopathology / Q000517:prevention & control*; D007249:Inflammation / Q000097:blood / Q000382:microbiology / Q000517:prevention & control; D008055:Lipids / Q000097:blood*; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D000975:Antioxidants; D015415:Biomarkers; D008055:Lipids; D002392:Catechin; C045651:epigallocatechin gallate